Please login to the form below

Not currently logged in
Email:
Password:

Alliance Life Sciences expands executive team

Four additions including Teresa Ferlo as VP global client development

morayea pindziak alliance life sciencesConsultancy and technology provider Alliance Life Sciences has made four additions to its executive team.

Teresa Ferlo joins as VP global client development and John Fulton has been named as director of the same sector, while Morayea Pindziak (pictured) will serve as VP marketing and Courtney Klauber will become marketing associate.

Jeffrey Erb, executive VP of global sales and marketing at Alliance Life Sciences, said: “To have a successful company, you need to be surrounded by highly skilled professionals who each bring unique strengths and abilities to the table.

“These individuals bring additional industry-specific knowledge and skill sets that will help advance Alliance in the market.”

Ferlo brings over 25 years of life sciences experience to the role and has previously held global business development positions at IMS Health, Managed Market Insights & Technology and ClearPoint Learning Systems.

Fulton has a background in developing pharma marketing solutions, and brings significant experience to the role having previously worked as a manager of his own health and wellness enterprise.

Pindziak has experience in building brands and working alongside thought leaders and has served as VP marketing at Harte Hanks and director of marketing at Publishing Technology.

Klauber recently graduated with proficiency in public relations and marketing communications through internships, student organisations and other professional work.

7th July 2015

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa
Ben Speller shares his thoughts on the value of disease specific congresses...
OPEN Health use PR to support clinical trial recruitment
International Clinical Trials Day finds clinical research in the spotlight like never before, with any news coming from the many studies into potential vaccines and treatments for SARS-CoV-2...
Covid-19: what could it mean for the diabetic population?
Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it...

Infographics